CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Wedbush Adjusts PT on First Tracks Biotherapeutics to $70 From $60, Maintains Outperform Rating

Positive
AI Analysis

Summary

Wedbush increased its price target on First Tracks Biotherapeutics from $60 to $70 while maintaining an Outperform rating.

Importance:2/10
Sentiment:
0.30
price_target_adjustmentanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on August 13, 2026 10:51 AM

Read Original